In this powerful conversation Rome talks with breast cancer conqueror Mary Royal, who shares her deeply personal experience with the fear and anxiety of cancer recurrence. Mary’s story takes a pivotal turn when she’s introduced to MRD (Molecular Residual Disease) testing, a groundbreaking technology also known as circulating tumor DNA (ctDNA) or form of liquid biopsy testing.
This innovative test detects minute fragments of cancer DNA shed by tumor cells into the bloodstream, often long before any symptoms appear or before traditional imaging scans can identify a relapse. MRD testing has potential to revolutionize the detection of cancer’s return after curative treatment by providing doctors 15-month (or more) lead time to catch a returning cancer at its earliest, most treatable stage, transforming what might have otherwise become an incurable situation into longer healthier life.
Mary’s narrative is not just about her fight against cancer; it’s a testament to overcoming fear, advocating for cutting-edge care, and championing a technology that promises to empower patients and redefine the future of cancer surveillance and treatment.
